What is Haemonetics's free cash flow?

Haemonetics generated free cash flow of $260.44M in fiscal 2026 (fiscal year ended Mar 31, 2026), operating cash flow of $293.22M minus $32.78M of capital expenditures. That was up 82.8% from $142.45M a year earlier. Free cash flow equaled 19.5% of revenue.

How much does Haemonetics spend on capital expenditures?

Haemonetics spent $32.78M on capital expenditures in fiscal 2026, compared with $39.28M a year earlier. That equals 11.2% of operating cash flow.

Does Haemonetics pay dividends or buy back shares?

Yes. In fiscal 2026 Haemonetics returned $175.00M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment.

Haemonetics (HAE) Cash Flow: Operating & Free Cash Flow

Haemonetics Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Haemonetics Corporation (HAE) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Mar 2025	Mar 2024	Apr 2023	Mar 2023	Apr 2022	Mar 2022	Apr 2021	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Operating Activities
Net Income	97.31	167.68	117.56	115.40	115.40	43.38	43.38	79.47	79.47	76.53	55.02	45.57	-26.27
Depreciation & Amortization	111.72	115.59	97.22	93.31	93.31	97.75	97.75	84.29	84.29	110.29	109.42	89.25	89.73
Deferred Income Tax	-0.71	-15.70	-1.01	-	4.78	-	5.01	-	-19.87	-6.96	13.35	-5.83	-6.80
Stock Based Compensation	33.83	29.64	28.33	25.58	25.58	24.36	24.36	25.52	25.52	20.45	17.19	13.03	9.15
Change in Working Capital	-12.93	-91.98	-63.07	25.50	25.50	-15.18	-15.18	-59.68	-59.68	-84.56	-62.75	76.49	-0.98
Change in Accounts Receivable	-14.88	6.96	-24.19	-24.42	-24.42	-34.97	-34.97	44.12	44.12	18.86	-38.06	5.09	3.16
Change in Inventory	47.36	-64.70	-60.06	30.75	30.75	24.31	24.31	-38.91	-38.91	-84.72	-39.32	14.39	-1.55
Change in Accounts Payable	-16.57	0.00	0.00	39.82	39.82	7.64	0.00	-56.42	0.00	-17.31	17.74	41.40	21.07
Change in Other Working Capital	3.94	-20.67	21.19	-22.33	8.82	-15.02	-4.51	-4.65	-64.89	-1.40	-3.10	57.02	-2.59
Other Operating Activities	3.94	-20.67	2.73	13.26	8.82	21.96	16.95	-20.79	-0.92	42.47	27.06	1.85	94.91
Net Cash from Operating Activities	293.22	181.73	181.75	273.06	273.06	172.26	172.26	108.81	108.81	158.22	159.28	220.35	159.74
Investing Activities
Capital Expenditures	-32.78	-39.28	-38.13	-191.33	-191.33	-96.51	-96.51	-37.04	-37.04	-48.76	-118.96	-74.80	-76.14
Acquisitions	-60.18	-150.91	-242.35	-2.85	-2.85	-2.50	8.14	-434.80	-390.22	-25.19	2.81	9.00	2.82
Purchases of Investments	0.00	0.00	0.00	-33.21	-33.21	-	0.00	-	0.00	0.00	0.00	0.00	0.00
Other Investing Activities	-87.96	-15.00	-41.91	47.93	1.61	51.80	2.02	9.29	1.82	16.77	2.81	2.76	2.82
Net Cash from Investing Activities	-179.55	-161.90	-322.39	-143.79	-143.79	-86.35	-86.35	-425.44	-425.44	-57.18	-116.15	-63.04	-73.31
Financing Activities
Debt Repayment	-306.25	-502.69	37.75	-339.63	-339.63	-17.50	-17.50	-21.88	418.13	31.88	95.93	-60.98	-93.41
Common Stock Issued	7.89	-1.91	1.33	7.02	0.00	6.55	0.00	10.23	0.00	0.00	0.00	0.00	0.00
Common Stock Repurchased	-175.00	-225.00	0.00	-75.00	-75.00	-	0.00	-	0.00	-175.00	-160.00	-100.00	0.00
Other Financing Activities	-0.10	-111.58	-0.92	-22.76	-22.76	-4.80	1.75	-60.90	-50.67	11.92	13.45	40.34	0.00
Net Cash from Financing Activities	-178.46	108.82	38.16	-100.36	-100.36	-15.75	-15.75	367.45	367.45	-131.21	-50.63	-120.64	-60.41
Summary
Effect of Forex Changes on Cash	3.46	-0.69	-3.19	-3.94	-3.94	-2.98	-2.98	4.18	4.18	-1.87	-3.32	3.94	-1.57
Net Change in Cash	-61.32	127.96	-105.67	24.97	24.97	67.19	67.19	54.99	54.99	-32.04	-10.82	40.61	24.44
Cash at Beginning of Period	306.76	178.80	284.47	-	259.50	-	192.31	-	137.31	169.35	180.17	139.56	115.12
Cash at End of Period	245.44	306.76	178.80	-	284.47	-	259.50	-	192.31	137.31	169.35	180.17	139.56
Free Cash Flow	260.44	142.45	143.63	81.73	81.73	75.75	75.75	71.77	71.77	109.46	40.32	145.55	83.60
Supplemental Disclosures
Interest Paid	-	16.53	20.90	13.59	-	6.19	-	7.82	-	-	-	-	-
Income Taxes Paid	-	49.29	52.71	17.97	-	24.30	-	12.49	-	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Haemonetics (HAE) Cash Flow Statement

Haemonetics Cash Flow Statement Analysis

Frequently Asked Questions About Haemonetics Cash Flow